Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD) Receives $8.60 Average Price Target from Analysts
Ironwood Pharmaceuticals, Inc. (NASDAQ:IRWD – Get Free Report) has been assigned a consensus recommendation of “Moderate Buy” ...